As private markets mature and competition intensifies, investors are searching for ways to better measure risk, performance and true manager outperformance.
Peer‑group comparisons and fund‑level IRRs may tell part of the story, but they are insufficient for knowing whether a GP is really achieving the alpha they might claim.
In this episode, Frédéric Blanc‑Brude...